EIT Health-funded BRIGHT project investigates stratified breast cancer screening based on genetic risk estimated with polygenic risk scores. This involves assessing women for their genetic predisposition to breast cancer from the age of 35 or 40 and provide personalized risk-based screening recommendations. The project includes clinical studies in Estonia, Sweden and Portugal. Each country has recruited 800 women in the clinical implementation study. 

The goal of the international BRIGHT project is to implement screening based on genetic risk assessment for breast cancer, involving research and innovation partners, healthcare providers, health insurance providers and patient organizations. 

BRIGHT project partners are Region Uppsala, North Lisbon University Hospital Centre, University of Tartu, Tartu University Hospital, Antegenes, Estonian Health Insurance Fund, IESE Business School and GE Healthcare. 

The seminar presents preliminary results and discusses the opportunities related to implementation of breast cancer precision prevention in healthcare. You can also participate in the event through Zoom by registering yourself in the registration form, and the link will be sent to your email before the event.

Date: Monday, April 22, 2024
Time: 14.00-16.00
Venue: Psykiatrin hus, Nordlandersalen
Akademiska Sjukhuset (Uppsala University Hospital)

Please inform us of your participation in the event by filling out the registration form: https://forms.gle/1c2EhqWR4gYkBXt18